← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2016Last known activity
Oct 3, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT05473520CollaboratorPhase 3Oct 3, 2022
- NCT04512196Lead sponsorN/ASep 9, 2020
- NCT04512196Overall official - principal investigatorN/ASep 9, 2020
- NCT03056391Overall official - principal investigatorPhase 3Oct 1, 2016
Details
- Last known activity
- Oct 3, 2022